(Q33365077)

English

Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

1 reference

based on heuristic

inferred from title

Dimosthenis Skarlos

8

object named as

Dimosthenis Skarlos

0 references

Christos Christodoulou

1

object named as

Christos Christodoulou

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Dimitrios Bafaloukos

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Helen Linardou

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Gerassimos Aravantinos

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Aristotelis Bamias

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Maria Carina

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

George Klouvas

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Hellenic Cooperative Oncology Group

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Journal of Neuro-Oncology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

71

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

61-65

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inactivation of O6-alkylguanine-DNA alkyltransferase in HeLa cells by cisplatin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Demographics of brain metastasis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Surgical treatment of 70 patients with brain metastases from breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin increases sensitivity of human leukemic blasts to triazene compounds.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimal two-stage designs for phase II clinical trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary chemotherapy of brain metastasis in small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small cell lung cancer?

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brain metastases in breast cancer: prognostic factors and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II trial of temozolomide for patients with recurrent or progressive brain metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Attenuation of O(6)-methylguanine-DNA methyltransferase activity and mRNA levels by cisplatin and temozolomide in jurkat cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absorption, metabolism, and excretion of 14C-temozolomide following oral administration to patients with advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Front-line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brain metastases. Histology, multiplicity, surgery, and survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response of brain metastases from breast cancer to systemic chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response of brain metastases from lung cancer to systemic chemotherapy with carboplatin and etoposide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of brain metastases from lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognosis of patients treated for intracranial metastases with whole-brain irradiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of temozolomide against human tumor colony-forming units

1 reference

https://pubmed.ncbi.nlm.nih.gov/15719277

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11060-004-9176-0

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33365077&oldid=2195288633"